|
Wednesday 31st October 2012 |
Text too small? |
A2 Corp, which markets milk products with a protein variant claimed to have health benefits, wants to directly enter the New Zealand market and is looking to expand into North America and some European nations having wrapped up a strategic review to speed up growth.
The alternative-market listed company will shift its focus to a number of opportunities in a bid to ramp up growth, including directly marketing into New Zealand, it said in a statement. A2 plans to expand rapidly include entering markets in North America, German, France Italy and Spain via joint ventures, using local contract manufacturers or investing in regional processing, it said.
Other plans include developing its suite of intellectual property and patents, and to accelerate its existing investment in the UK and in China. A2 is also looking at expanding its product range to ultra-heat tested (UHT) milk and yoghurt.
"A2 is well placed to drive strong future growth independent, with an openness to engage with potential partners who may assist with its global ambitions," the company said. "By virtue of the capital light partnership model the company is well positioned to progressively fund its development through its internally generated cash flows and strong balance sheet."
The six-month review's results come a week after A2 entered into a Chinese distribution arrangement with China State Farm Holding Shanghai Company, a subsidiary of state-owned China National Agriculture Development Group Corp, as the exclusive distributor of its a2 brand infant formula.
The shares fell 1.5 percent to 67 cents, having surged 183 percent this year.
BusinessDesk.co.nz
No comments yet
A2 Corp's Babidge, Mair take advantage of soaring price to sell 6M shares
A2 shares touch record-high as investors buy into growth story
A2 FY profit slips on cost of setting up UK joint venture, sales jump 51 percent as Australian shines
A2 first-half profit dented by UK joint venture, affirms annual earnings target of $11.2M
A2 to raise $20M in placement, big shareholders sell down
A2 Corp mulls capital structure in face of growth opportunities
A2 Corp, in talks to move to main board, halts shares pending statement
A2 in talks with NZX about shifting to main board
A2 Corp talks up Chinese infant formula market potential
A2 more than doubles FY profit as Australian sales surge
